Insightful Forecast Report On Cancer Profiling Market: Size, Share, Growth, Top Players Analysis, And Projections Till 2032 || Illumina Inc., Qiagen N.V., NeoGenomics Inc., Sysmex Corporation

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

Cancer Profiling Market Size, Growth Rate, And Forecast

The global cancer profiling market size is expected to grow from $10.59 billion in 2022 to $11.93 billion in 2023 at a compound annual growth rate (CAGR) of 12.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global cancer profiling market size is expected to reach $18.29 billion in 2027 at a CAGR of 11.3%.

Request A Free Sample Of The Cancer Profiling Market Report Here ---
https://www.thebusinessresearchcompany.com/sample.aspx?id=9912&type=smp

Cancer Profiling Market Drivers

The increasing incidence of cancer is expected to propel the growth of the cancer profiling market going forward. Incidence of cancer refers to the number of new cancer cases in a specific population for a given period. The increased incidence of cancer caused due to urbanization, a growing aging population, changing lifestyles, and environmental and genetic factors. Cancer profiling aids in the identification of specific molecular or genetic changes in a tumor, such as gene mutations or other changes in tumor DNA, which is helpful in the cancer treatment cycle. For instance, in 2020, according to the national cancer registry report released by the National Centre for Disease Informatics and Research (NCDIR), an India-based institution, cancer cases in men are estimated to be 763,575 in 2025, while among women, the cancer cases are estimated to be 806,218 in 2025 which is significantly higher than the current cases of cancer. Additionally, in 2022, according to the American Cancer Society, a US-based voluntary organization, the number of new cancer cases and fatalities expected was estimated to be 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. Therefore, the increasing incidence of cancer is driving the growth of the cancer profiling market.

Learn More On The Cancer Profiling Market Report Here:
https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Cancer Profiling Market Segments

• By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization

• By Biomarker Type: Genomic Biomarkers, Protein Biomarkers

• By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers

• By Application: Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the cancer profiling market.

Check Out Buying Options For The Cancer Profiling Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9912

Cancer Profiling Market Key Players
Major competitors in the cancer profiling market are Illumina Inc., Qiagen N.V., NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine, Roche Diagnostics, F. Hoffmann-La Roche Ltd.

The Business Research Company's "Global Cancer Profiling Market Report 2023" is a comprehensive report of the market, covering over 60 geographies and high level market segmentation per geography. The section on regional and country breakdowns examines the market in each geography as well as market size by region and country. Furthermore, it evaluates the market's historical and projected growth and identifies significant trends and strategies that businesses can use to expand their operations.

The Table Of Content For The Cancer Profiling Market Include:
1. Executive Summary
2. Cancer Profiling Market Characteristics
3. Cancer Profiling Market Trends And Strategies
4. Cancer Profiling Market - Macro Economic Scenario
5. Cancer Profiling Market Size And Growth
………………
27. Cancer Profiling Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Cancer Profiling Market
29. Cancer Profiling Market Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, seafood, seafood, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic.

This release was published on openPR.